{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:00:46Z","timestamp":1795111246438,"version":"4.10.3"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.compbiomed.2021.105149","type":"journal-article","created":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T02:01:52Z","timestamp":1639706512000},"page":"105149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"special_numbering":"C","title":["In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus"],"prefix":"10.1016","volume":"141","author":[{"given":"Dalia","family":"Elebeedy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingy","family":"Badawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4634-3039","authenticated-orcid":false,"given":"Ayman Abo","family":"Elmaaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustafa M.","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3253-6961","authenticated-orcid":false,"given":"Ahmed","family":"Kandeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aml","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omnia","family":"Kutkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwan","family":"Alnajjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed I.","family":"Abd El Maksoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Al-karmalawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.compbiomed.2021.105149_bib1","doi-asserted-by":"crossref","first-page":"654","DOI":"10.3390\/cells8070654","article-title":"Viroporins in the influenza virus","volume":"8","author":"To","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.compbiomed.2021.105149_bib2","series-title":"Pediatric Secrets","first-page":"354","article-title":"CHAPTER 11 - Infectious Diseases","author":"Ditmar","year":"2011"},{"issue":"2","key":"10.1016\/j.compbiomed.2021.105149_bib3","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1440-1843.2003.00457.x","article-title":"Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients","volume":"8","author":"Kaji","year":"2003","journal-title":"Respirology"},{"key":"10.1016\/j.compbiomed.2021.105149_bib4","first-page":"1","article-title":"Incidence and costs of hospitalized adult influenza patients in The Netherlands: a retrospective observational study","author":"Marbus","year":"2020","journal-title":"Eur. J. Health Econ."},{"issue":"37","key":"10.1016\/j.compbiomed.2021.105149_bib5","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1074\/jbc.R110.129809","article-title":"Influenza hemagglutinin and neuraminidase membrane glycoproteins*","volume":"285","author":"Gamblin","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.105149_bib6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.aogh.2015.08.014","article-title":"Treatment and prevention of pandemic H1N1 influenza","volume":"81","author":"Rewar","year":"2015","journal-title":"Ann. Global Health"},{"issue":"4","key":"10.1016\/j.compbiomed.2021.105149_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.2478\/aoas-2019-0043","article-title":"Herbal medicine additives as powerful agents to control and prevent avian influenza virus in poultry\u2013a review","volume":"19","author":"Gado","year":"2019","journal-title":"Ann. Anim. Sci."},{"issue":"11","key":"10.1016\/j.compbiomed.2021.105149_bib8","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3390\/vaccines9111317","article-title":"Coronavirus disease (COVID-19) control between drug repurposing and vaccination: a comprehensive overview","volume":"9","author":"Al-Karmalawy","year":"2021","journal-title":"Vaccines"},{"issue":"20","key":"10.1016\/j.compbiomed.2021.105149_bib9","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.3390\/molecules26206182","article-title":"In silico and in vivo evaluation of SARS-CoV-2 predicted epitopes-based candidate vaccine","volume":"26","author":"Shehata","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.compbiomed.2021.105149_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1743-422X-6-51","article-title":"Towards a sane and rational approach to management of Influenza H1N1 2009","volume":"6","author":"Gallaher","year":"2009","journal-title":"Virol. J."},{"key":"10.1016\/j.compbiomed.2021.105149_bib11","first-page":"47","article-title":"Design of multiligand inhibitors for the swine flu H1N1 neuraminidase binding site","volume":"6","author":"Narayanan","year":"2013","journal-title":"Comput. Biol. Chem. Adv. Appl. : AABC"},{"key":"10.1016\/j.compbiomed.2021.105149_bib12","series-title":"The Success of Natural Products in Drug Discovery","author":"Lahlou","year":"2013"},{"issue":"40","key":"10.1016\/j.compbiomed.2021.105149_bib13","doi-asserted-by":"crossref","first-page":"17374","DOI":"10.1039\/D0NJ04088F","article-title":"Tanshinone IIA synergistically enhances the antitumor activity of doxorubicin by interfering with the PI3K\/AKT\/mTOR pathway and inhibition of topoisomerase II: in vitro and molecular docking studies","volume":"44","author":"Ghanem","year":"2020","journal-title":"New J. Chem."},{"issue":"9","key":"10.1016\/j.compbiomed.2021.105149_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.14715\/cmb\/2017.63.9.10","article-title":"Regulation of signaling pathways by tanshinones in different cancers","volume":"63","author":"Lin","year":"2017","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.compbiomed.2021.105149_bib15","article-title":"Anti-inflammatory and immunomodulatory mechanism of tanshinone IIA for atherosclerosis","volume":"2014","author":"Chen","year":"2014","journal-title":"Evid. base Compl. Alternative Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2021.105149_bib16","first-page":"2955","article-title":"Tanshinone IIA attenuates paraquat-induced acute lung injury by modulating angiotensin-converting enzyme 2\/angiotensin-(1-7) in rats","volume":"18","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.105149_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178226","article-title":"Sodium tanshinone IIA sulfonate stimulated Cl\u2212 secretion in mouse trachea","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiomed.2021.105149_bib18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.phytochem.2014.12.026","article-title":"Carnosic acid","volume":"115","author":"Birti\u0107","year":"2015","journal-title":"Phytochemistry"},{"issue":"1","key":"10.1016\/j.compbiomed.2021.105149_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-10-303","article-title":"Antiviral activity of carnosic acid against respiratory syncytial virus","volume":"10","author":"Shin","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.compbiomed.2021.105149_bib20","doi-asserted-by":"crossref","DOI":"10.2174\/1568026619666191118110155","article-title":"Rosmarinic acid as a potent influenza neuraminidase inhibitor: in vitro and in silico study","author":"Mahalapbutr","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"9","key":"10.1016\/j.compbiomed.2021.105149_bib21","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1128\/AAC.00041-07","article-title":"Antiviral and anti-inflammatory effects of rosmarinic acid in an experimental murine model of Japanese encephalitis","volume":"51","author":"Swarup","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.compbiomed.2021.105149_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.antiviral.2017.04.010","article-title":"Anti-inflammatory effects of rosmarinic acid-4-O-\u03b2-D-glucoside in reducing acute lung injury in mice infected with influenza virus","volume":"144","author":"Liu","year":"2017","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.105149_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.14200\/jrm.2014.3.0109","article-title":"Rosmarinic acid as a novel agent in the treatment of allergies and asthma","volume":"3","author":"Stansbury","year":"2014","journal-title":"J. Restor. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2021.105149_bib24","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.fct.2007.06.034","article-title":"Characterization of the radical scavenging and antioxidant activities of danshensu and salvianolic acid B","volume":"46","author":"Zhao","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.compbiomed.2021.105149_bib25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainresbull.2015.05.002","article-title":"Salvianolic acid B attenuates apoptosis and inflammation via SIRT1 activation in experimental stroke rats","volume":"115","author":"Lv","year":"2015","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.compbiomed.2021.105149_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.taap.2016.08.004","article-title":"Salvianolic acid B protects against paraquat-induced pulmonary injury by mediating Nrf2\/Nox4 redox balance and TGF-\u03b21\/Smad3 signaling","volume":"309","author":"Liu","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"12","key":"10.1016\/j.compbiomed.2021.105149_bib27","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1016\/j.apsb.2020.06.008","article-title":"Inhibitory effects of baicalein against herpes simplex virus type 1","volume":"10","author":"Luo","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"issue":"1\u20132","key":"10.1016\/j.compbiomed.2021.105149_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0014-2999(03)01378-5","article-title":"Mechanisms in mediating the anti-inflammatory effects of baicalin and baicalein in human leukocytes","volume":"465","author":"Shen","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.compbiomed.2021.105149_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s11094-010-0348-2","article-title":"Prospects for the creation of new antiviral drugs based on glycyrrhizic acid and its derivatives (a review)","volume":"43","author":"Baltina","year":"2009","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.compbiomed.2021.105149_bib30","series-title":"Computational Approaches for Drug Discovery","author":"Brogi","year":"2019"},{"issue":"6","key":"10.1016\/j.compbiomed.2021.105149_bib31","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/vaccines9060669","article-title":"In silico prediction of a multitope vaccine against Moraxella catarrhalis: reverse vaccinology and immunoinformatics","volume":"9","author":"Soltan","year":"2021","journal-title":"Vaccines"},{"issue":"17","key":"10.1016\/j.compbiomed.2021.105149_bib32","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.3390\/ijms22179330","article-title":"Proteome based approach defines candidates for designing a multitope vaccine against the Nipah virus","volume":"22","author":"Soltan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2021.105149_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3389\/fphar.2020.00153","article-title":"A review of the anti-inflammatory effects of rosmarinic acid on inflammatory diseases","volume":"11","author":"Luo","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.compbiomed.2021.105149_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2021.100604","article-title":"The journey of antimalarial drugs against SARS-CoV-2: review article","author":"Sarhan","year":"2021","journal-title":"Inf. Med. Unlocked"},{"key":"10.1016\/j.compbiomed.2021.105149_bib35","article-title":"Pirfenidone and vitamin D mitigate renal fibrosis induced by doxorubicin in mice with Ehrlich solid tumor","author":"Hazem","year":"2021","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.compbiomed.2021.105149_bib36","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.3390\/molecules26123772","article-title":"Computational insights on the potential of some NSAIDs for treating COVID-19: priority set and lead optimization","volume":"26","author":"Abo Elmaaty","year":"2021","journal-title":"Molecules"},{"issue":"227","key":"10.1016\/j.compbiomed.2021.105149_bib37","article-title":"Molecular docking and dynamics simulation revealed the potential inhibitory activity of ACEIs against SARS-CoV-2 targeting the hACE2 receptor","volume":"9","author":"Al-Karmalawy","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiomed.2021.105149_bib38","article-title":"Molecular docking and dynamics simulations reveal the potential of anti-HCV drugs to inhibit COVID-19 main protease","author":"Al\u2010Karmalawy","year":"2021","journal-title":"Pharmaceut. Sci."},{"key":"10.1016\/j.compbiomed.2021.105149_bib39","unstructured":"Al\u2010Karmalawy, A.A. and M.F. Elshal, Concanavalin-A Shows Synergistic Cytotoxicity with Tamoxifen via Inducing Apoptosis in Estrogen Receptor-Positive Breast Cancer: in Vitro and Molecular Docking Studies."},{"issue":"33","key":"10.1016\/j.compbiomed.2021.105149_bib40","doi-asserted-by":"crossref","first-page":"13990","DOI":"10.1039\/D0NJ02844D","article-title":"Molecular modelling of mebendazole polymorphs as a potential colchicine binding site inhibitor","volume":"44","author":"Al-Karmalawy","year":"2020","journal-title":"New J. Chem."},{"issue":"12","key":"10.1016\/j.compbiomed.2021.105149_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2020.e05641","article-title":"Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease","volume":"6","author":"Alnajjar","year":"2020","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.compbiomed.2021.105149_bib42","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1021\/acsptsci.0c00144","article-title":"Empagliflozin and doxorubicin synergistically inhibit the survival of triple-negative breast cancer cells via interfering with the mTOR pathway and inhibition of calmodulin: in vitro and molecular docking studies","volume":"3","author":"Eliaa","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"issue":"17","key":"10.1016\/j.compbiomed.2021.105149_bib43","doi-asserted-by":"crossref","first-page":"10027","DOI":"10.1039\/D0RA10674G","article-title":"Revisiting activity of some glucocorticoids as a potential inhibitor of SARS-CoV-2 main protease: theoretical study","volume":"11","author":"Elmaaty","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2021.105149_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fchem.2021.628398","article-title":"Revisiting activity of some Nocodazole analogues as a potential anticancer drugs using molecular docking and DFT calculations","volume":"9","author":"Khattab","year":"2021","journal-title":"Front. Chem."},{"issue":"9","key":"10.1016\/j.compbiomed.2021.105149_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07962","article-title":"Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and <em>in vitro<\/em> studies","volume":"7","author":"Mahmoud","year":"2021","journal-title":"Heliyon"},{"issue":"5","key":"10.1016\/j.compbiomed.2021.105149_bib46","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/pathogens10050623","article-title":"Strong inhibitory activity and action modes of synthetic maslinic acid derivative on highly pathogenic coronaviruses: COVID-19 drug candidate","volume":"10","author":"Soltane","year":"2021","journal-title":"Pathogens"},{"issue":"19","key":"10.1016\/j.compbiomed.2021.105149_bib47","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.3390\/molecules26195844","article-title":"Pimenta dioica (L.) Merr. Bioactive constituents exert anti-SARS-CoV-2 and anti-inflammatory activities: molecular docking and dynamics, in vitro, and in vivo studies","volume":"26","author":"El Gizawy","year":"2021","journal-title":"Molecules"},{"issue":"50","key":"10.1016\/j.compbiomed.2021.105149_bib48","doi-asserted-by":"crossref","first-page":"31339","DOI":"10.1039\/D1RA05817G","article-title":"Investigating the structure\u2013activity relationship of marine natural polyketides as promising SARS-CoV-2 main protease inhibitors","volume":"11","author":"El-Demerdash","year":"2021","journal-title":"RSC Adv."},{"issue":"47","key":"10.1016\/j.compbiomed.2021.105149_bib49","doi-asserted-by":"crossref","first-page":"29267","DOI":"10.1039\/D1RA05268C","article-title":"Anti-SARS-CoV-2 activities of tanshinone IIA, carnosic acid, rosmarinic acid, salvianolic acid, baicalein, and glycyrrhetinic acid between computational and in vitro insights","volume":"11","author":"Elebeedy","year":"2021","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiomed.2021.105149_bib50","first-page":"1","article-title":"In a search for potential drug candidates for combating COVID-19: computational study revealed salvianolic acid B as a potential therapeutic targeting 3CLpro and spike proteins","author":"Elmaaty","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"6","key":"10.1016\/j.compbiomed.2021.105149_bib51","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/pathogens10060758","article-title":"Bioactive polyphenolic compounds showing strong antiviral activities against severe acute respiratory syndrome Coronavirus 2","volume":"10","author":"Kandeil","year":"2021","journal-title":"Pathogens"},{"key":"10.1016\/j.compbiomed.2021.105149_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2021.102845","article-title":"Delineating a potent antiviral activity of Cuphea ignea extract loaded nano-formulation against SARS-CoV-2: in silico and in vitro studies","author":"Mahmoud","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"39","key":"10.1016\/j.compbiomed.2021.105149_bib53","doi-asserted-by":"crossref","first-page":"16752","DOI":"10.1039\/D0NJ03611K","article-title":"Molecular docking reveals the potential of Cleome amblyocarpa isolated compounds to inhibit COVID-19 virus main protease","volume":"44","author":"Zaki","year":"2020","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2021.105149_bib54","article-title":"Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: molecular docking, molecular dynamics, and SAR studies","author":"Zaki","year":"2021","journal-title":"J. Tradit. Complementary. Med."},{"key":"10.1016\/j.compbiomed.2021.105149_bib55","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.sajb.2021.02.007","article-title":"Bioassay-guided isolation of a new cytotoxic ceramide from Cyperus rotundus L","volume":"139","author":"Samra","year":"2021","journal-title":"South Afr. J. Bot."},{"key":"10.1016\/j.compbiomed.2021.105149_bib56","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.sajb.2021.08.006","article-title":"Isolation of cytotoxic active compounds from Reichardia tingitana with investigation of apoptosis mechanistic induction: in silico, in vitro, and SAR studies","volume":"144","author":"Zaki","year":"2022","journal-title":"South Afr. J. Bot."},{"issue":"4","key":"10.1016\/j.compbiomed.2021.105149_bib57","doi-asserted-by":"crossref","DOI":"10.34172\/jhp.2021.52","article-title":"Two new flavonoids and anticancer activity of Hymenosporum flavum: in vitro and molecular docking studies","volume":"10","author":"Taher","year":"2021","journal-title":"J. Herbmed Pharmacol."},{"issue":"5","key":"10.1016\/j.compbiomed.2021.105149_bib58","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/AAC.17.5.865","article-title":"Plaque inhibition assay for drug susceptibility testing of influenza viruses","volume":"17","author":"Hayden","year":"1980","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.compbiomed.2021.105149_bib59","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3390\/ph13120443","article-title":"FDA-approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome Coronavirus 2","volume":"13","author":"Mostafa","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.compbiomed.2021.105149_bib60","series-title":"Molecular Operating Environment (MOE)","author":"Inc","year":"2016"},{"key":"10.1016\/j.compbiomed.2021.105149_bib61","doi-asserted-by":"crossref","DOI":"10.1039\/D1NJ02885E","article-title":"Design and synthesis of a new series of 3,5-Disubstituted-1,2,4-oxadiazoles as potential colchicine binding site inhibitors: antiproliferative activity, molecular docking, and SAR studies","author":"Diab","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2021.105149_bib62","doi-asserted-by":"crossref","DOI":"10.1039\/D1NJ02710G","article-title":"Design and synthesis of new 4-(2-nitrophenoxy)benzamide derivatives as potential antiviral agents: molecular modeling and in vitro antiviral screening","author":"Abdallah","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2021.105149_bib63","series-title":"Design and Discovery of New 1, 2, 4\u2010triazolo [4, 3\u2010c] Quinazolines as Potential DNA Intercalators and Topoisomerase II Inhibitors","author":"Alesawy","year":"2020"},{"issue":"56","key":"10.1016\/j.compbiomed.2021.105149_bib64","doi-asserted-by":"crossref","first-page":"35536","DOI":"10.1039\/D1RA04820A","article-title":"\u03b2-Blockers bearing hydroxyethylamine and hydroxyethylene as potential SARS-CoV-2 Mpro inhibitors: rational based design, in silico, in vitro, and SAR studies for lead optimization","volume":"11","author":"Hamed","year":"2021","journal-title":"RSC Adv."},{"issue":"31","key":"10.1016\/j.compbiomed.2021.105149_bib65","doi-asserted-by":"crossref","first-page":"18431","DOI":"10.1073\/pnas.2006893117","article-title":"An influenza A hemagglutinin small-molecule fusion inhibitor identified by a new high-throughput fluorescence polarization screen","volume":"117","author":"Yao","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"7199","key":"10.1016\/j.compbiomed.2021.105149_bib66","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/nature06956","article-title":"Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants","volume":"453","author":"Collins","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2021.105149_bib67","first-page":"648","article-title":"Design and synthesis of new quinoxaline derivatives as potential histone Deacetylase inhibitors targeting hepatocellular carcinoma: in silico, in vitro, and SAR studies","author":"Al-Karmalawy","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.compbiomed.2021.105149_bib68","first-page":"null","article-title":"Computational repurposing of benzimidazole anthelmintic drugs as potential colchicine binding site inhibitors","author":"Khattab","year":"2021","journal-title":"Future Med. Chem."},{"issue":"4","key":"10.1016\/j.compbiomed.2021.105149_bib69","doi-asserted-by":"crossref","first-page":"443","DOI":"10.34172\/jhp.2021.52","article-title":"Two new flavonoids and anticancer activity of Hymenosporum flavum: in vitro and molecular docking studies","volume":"10","author":"Taher","year":"2021","journal-title":"J. Herbmed Pharmacol."},{"key":"10.1016\/j.compbiomed.2021.105149_bib70","article-title":"Loperamide potentiates doxorubicin sensitivity in triple-negative breast cancer cells by targeting MDR1 and JNK and suppressing mTOR and Bcl-2: in vitro and molecular docking study","author":"Elia","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"19","key":"10.1016\/j.compbiomed.2021.105149_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910396","article-title":"Design, synthesis, biological evaluation, 2D-QSAR modeling, and molecular docking studies of novel 1H-3-Indolyl derivatives as significant antioxidants","volume":"22","author":"Aziz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.compbiomed.2021.105149_bib72","doi-asserted-by":"crossref","DOI":"10.1039\/D1NJ02663A","article-title":"Cordyline fruticosa (L.) A. Chev. leaves: isolation, HPLC\/MS profiling and evaluation of nephroprotective and hepatoprotective activities supported by molecular docking","author":"Raslan","year":"2021","journal-title":"New J. Chem."},{"issue":"10","key":"10.1016\/j.compbiomed.2021.105149_bib73","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3390\/horticulturae7100402","article-title":"Nanobiotechnological approaches to enhance potato resistance against potato Leafroll virus (PLRV) using glycyrrhizic acid ammonium salt and salicylic acid nanoparticles","volume":"7","author":"Shoala","year":"2021","journal-title":"Horticulturae"},{"key":"10.1016\/j.compbiomed.2021.105149_bib74","doi-asserted-by":"crossref","DOI":"10.1039\/D1NJ02838C","article-title":"The antimicrobial potential and pharmacokinetic profiles of novel quinoline-based scaffolds: synthesis and in silico mechanistic studies as dual DNA gyrase and DHFR inhibitors","author":"El-Shershaby","year":"2021","journal-title":"New J. Chem."},{"key":"10.1016\/j.compbiomed.2021.105149_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116266","article-title":"From triazolophthalazines to triazoloquinazolines: a bioisosterism-guided approach toward the identification of novel PCAF inhibitors with potential anticancer activity","volume":"42","author":"El-Shershaby","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiomed.2021.105149_bib76","article-title":"Pharmacophore-linked pyrazolo[3,4-d]pyrimidines as EGFR-TK inhibitors: synthesis, anticancer evaluation, pharmacokinetics, and in silico mechanistic studies","author":"Gaber","year":"2021","journal-title":"Arch. Pharmazie"},{"issue":"21","key":"10.1016\/j.compbiomed.2021.105149_bib77","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.3390\/molecules26216559","article-title":"Naturally available flavonoid aglycones as potential antiviral drug candidates against SARS-CoV-2","volume":"26","author":"Al-Karmalawy","year":"2021","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.compbiomed.2021.105149_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e08148","article-title":"In vitro and in silico characterization of alkaline serine protease from Bacillus subtilis D9 recovered from Saudi Arabia","volume":"7","author":"Mahmoud","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.compbiomed.2021.105149_bib79","series-title":"3: Desmond Molecular Dynamics System, DE Shaw Research","author":"Release","year":"2017"}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482521009434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482521009434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:18:59Z","timestamp":1791206339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482521009434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":79,"alternative-id":["S0010482521009434"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2021.105149","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro and computational insights revealing the potential inhibitory effect of Tanshinone IIA against influenza A virus","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2021.105149","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105149"}}